CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/1550/ihc_cell_selected_60x60.jpg) | ![](/images/10102/25628_B_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/17107/39741_A_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20398/109529_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Transporters
| ![](/images/55123/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55123/140100_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| ![](/images/2214/ihc_selected_60x60.jpg) | ![](/images/45939/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2214/6204_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
COLCA1 | Colorectal cancer associated 1 | Predicted membrane proteins
| ![](/images/12540/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/12540/ihc_cell_selected_60x60.jpg) | ![](/images/12540/29301_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
CRYBA2 | Crystallin, beta A2 | Disease related genes
| ![](/images/45913/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45913/103279_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/37692/ihc_selected_60x60.jpg) | ![](/images/49227/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37692/81903_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted membrane proteins
| ![](/images/64159/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64159/141447_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
EPN3 | Epsin 3 | | ![](/images/55546/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55546/128756_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FA2H | Fatty acid 2-hydroxylase | Disease related genes Predicted membrane proteins
| ![](/images/56614/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56614/138001_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
FAM177B | Family with sequence similarity 177, member B | | ![](/images/63059/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63059/143453_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
FAM83E | Family with sequence similarity 83, member E | | ![](/images/49305/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49305/113000_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
FER1L6 | Fer-1-like 6 (C. elegans) | Plasma proteins Predicted membrane proteins
| ![](/images/54117/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54117/126851_B_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1388/3095_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66032/149456_A_6_5_rna_selected_60x60.jpg) | Tissue enhanced |
GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8963/24612_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
GALNT6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) | Enzymes Predicted secreted proteins
| | ![](/images/17086/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17086/39520_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes
| ![](/images/37431/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37431/78834_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/22710/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22710/112109_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
GPR142 | G protein-coupled receptor 142 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/31392/ihc_selected_60x60.jpg) | ![](/images/31392/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31392/66788_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
HAP1 | Huntingtin-associated protein 1 | Cytoskeleton related proteins
| ![](/images/23394/ihc_selected_60x60.jpg) | ![](/images/23394/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23394/51885_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/49046/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/49046/ihc_cell_selected_60x60.jpg) | ![](/images/49046/110301_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | | | ![](/images_static/na_center.gif) | ![](/images/45546/ihc_cell_selected_60x60.jpg) | ![](/images/45546/102877_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
INSM1 | Insulinoma-associated 1 | Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| ![](/images/57416/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/57416/132767_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47218/116820_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47218/116820_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
LIPH | Lipase, member H | Disease related genes Predicted secreted proteins
| ![](/images/49079/ihc_selected_60x60.jpg) | ![](/images/49079/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49079/112554_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
LL22NC03-75H12.2 | Novel protein; Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MARCH4 | Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase | Predicted membrane proteins
| ![](/images/14348/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14348/34996_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
MBOAT4 | Membrane bound O-acyltransferase domain containing 4 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MCIDAS | Multiciliate differentiation and DNA synthesis associated cell cycle protein | | ![](/images/49981/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49981/113048_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
MFSD4 | Major facilitator superfamily domain containing 4 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/14685/57496_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
MMEL1 | Membrane metallo-endopeptidase-like 1 | Enzymes
| ![](/images/8205/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8205/23017_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MST1R | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | CD markers Enzymes Predicted membrane proteins
| ![](/images/8180/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8180/22749_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/8855/25361_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MYEOV | Myeloma overexpressed | Predicted membrane proteins
| ![](/images/12949/ihc_selected_60x60.jpg) | ![](/images/12949/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12949/29762_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
MYRF | Myelin regulatory factor | Enzymes Plasma proteins Predicted membrane proteins Transcription factors
| ![](/images/18310/ihc_selected_60x60.jpg) | ![](/images/18310/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18310/41992_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
NKX2-2 | NK2 homeobox 2 | Transcription factors
| ![](/images/3468/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3468/10934_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
NMUR2 | Neuromedin U receptor 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/45836/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45836/105592_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
NPAS1 | Neuronal PAS domain protein 1 | Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
NPW | Neuropeptide W | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |